Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxine Sun

Showing results (21-30 of 401) with videos related to

Pageof 41
Sort By:
The Lancet. Oncology|November 3, 2012
Conditional survival of patients with metastatic renal-cell carcinomaMaxine Sun, Quoc-Dien Trinh, Pierre I Karakiewicz
Current Urology Reports|January 14, 2014
Trends in surgical management of T1 renal cell carcinomaJonas Schiffmann, Marco Bianchi, Maxine Sun, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 31, 2010
Should all men having a radical prostatectomy have a pelvic lymph node dissection? NoFiras Abdollah, Maxine Sun, Rodolphe Thuret, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014
PISCES: a horoscope for first-line targeted therapy of metastatic renal cell carcinomaMaxine Sun, Alessandro Larcher, Jonas Schiffmann, et al.
Nature Reviews. Urology|May 12, 2010
Treatment of metastatic renal cell carcinomaMaxine Sun, Giovanni Lughezzani, Paul Perrotte, et al.
European Urology|April 22, 2014
Reply to E. David Crawford and Bo-Eric Persson's letter to the editor re: Giorgio Gandaglia, Maxine Sun, Jim C. Hu, et al. Gonadotropin-releasing hormone agonists and acute kidney injury in patients with prostate cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.01.026Giorgio Gandaglia, Maxine Sun, Alberto Briganti, et al.
Future Oncology (London, England)|September 12, 2015
Robot-assisted radical prostatectomy in prostate cancerGiorgio Gandaglia, Francesco Montorsi, Pierre I Karakiewicz, et al.
Nature Reviews. Urology|June 11, 2010
Pazopanib trial data cannot support first-line useClaudio Jeldres, Maxine Sun, Paul Perrotte, et al.
European Urology|April 10, 2012
Insights of modern pathology reports originating from prostate biopsy and radical prostatectomy specimensMaxine Sun, Marco Bianchi, Jens Hansen, et al.
Urologic Oncology|October 2, 2010
Decision curve analysis to compare 3 versions of Partin Tables to predict final pathologic stageHerbert Augustin, Maxine Sun, Hendrik Isbarn, et al.
Pageof 41

Showing results (21-30 of 401) with videos related to

Sort By:
Pageof 41
The Lancet. Oncology|November 3, 2012
Conditional survival of patients with metastatic renal-cell carcinomaMaxine Sun, Quoc-Dien Trinh, Pierre I Karakiewicz
Current Urology Reports|January 14, 2014
Trends in surgical management of T1 renal cell carcinomaJonas Schiffmann, Marco Bianchi, Maxine Sun, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 31, 2010
Should all men having a radical prostatectomy have a pelvic lymph node dissection? NoFiras Abdollah, Maxine Sun, Rodolphe Thuret, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014
PISCES: a horoscope for first-line targeted therapy of metastatic renal cell carcinomaMaxine Sun, Alessandro Larcher, Jonas Schiffmann, et al.
Nature Reviews. Urology|May 12, 2010
Treatment of metastatic renal cell carcinomaMaxine Sun, Giovanni Lughezzani, Paul Perrotte, et al.
European Urology|April 22, 2014
Reply to E. David Crawford and Bo-Eric Persson's letter to the editor re: Giorgio Gandaglia, Maxine Sun, Jim C. Hu, et al. Gonadotropin-releasing hormone agonists and acute kidney injury in patients with prostate cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.01.026Giorgio Gandaglia, Maxine Sun, Alberto Briganti, et al.
Future Oncology (London, England)|September 12, 2015
Robot-assisted radical prostatectomy in prostate cancerGiorgio Gandaglia, Francesco Montorsi, Pierre I Karakiewicz, et al.
Nature Reviews. Urology|June 11, 2010
Pazopanib trial data cannot support first-line useClaudio Jeldres, Maxine Sun, Paul Perrotte, et al.
European Urology|April 10, 2012
Insights of modern pathology reports originating from prostate biopsy and radical prostatectomy specimensMaxine Sun, Marco Bianchi, Jens Hansen, et al.
Urologic Oncology|October 2, 2010
Decision curve analysis to compare 3 versions of Partin Tables to predict final pathologic stageHerbert Augustin, Maxine Sun, Hendrik Isbarn, et al.
Pageof 41